These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32307701)

  • 1. MR- proADM to detect specific types of organ failure in infection.
    Andrés C; Andaluz-Ojeda D; Cicuendez R; Nogales L; Martín S; Martin-Fernandez M; Almansa R; Calvo D; Esteban-Velasco MC; Vaquero-Roncero LM; Ríos-Llorente A; Sanchez-Barrado E; Muñoz-Bellvís L; Aldecoa C; Bermejo-Martin JF
    Eur J Clin Invest; 2020 Jun; 50(6):e13246. PubMed ID: 32307701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin and MR-Proadrenomedullin Combination with SOFA and qSOFA Scores for Sepsis Diagnosis and Prognosis: A Diagnostic Algorithm.
    Spoto S; Cella E; de Cesaris M; Locorriere L; Mazzaroppi S; Nobile E; Lanotte AM; Pedicino L; Fogolari M; Costantino S; Dicuonzo G; Ciccozzi M; Angeletti S
    Shock; 2018 Jul; 50(1):44-52. PubMed ID: 29023361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
    Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
    Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
    Bernal-Morell E; García-Villalba E; Vera MDC; Medina B; Martinez M; Callejo V; Valero S; Cinesi C; Piñera P; Alcaraz A; Marin I; Muñoz A; Cano A
    J Infect; 2018 Mar; 76(3):249-257. PubMed ID: 29246637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.
    Elke G; Bloos F; Wilson DC; Brunkhorst FM; Briegel J; Reinhart K; Loeffler M; Kluge S; Nierhaus A; Jaschinski U; Moerer O; Weyland A; Meybohm P;
    Crit Care; 2018 Mar; 22(1):79. PubMed ID: 29562917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction is an early indicator of sepsis and neutrophil degranulation of septic shock in surgical patients.
    Martin-Fernandez M; Vaquero-Roncero LM; Almansa R; Gómez-Sánchez E; Martín S; Tamayo E; Esteban-Velasco MC; Ruiz-Granado P; Aragón M; Calvo D; Rico-Feijoo J; Ortega A; Gómez-Pesquera E; Lorenzo-López M; López J; Doncel C; González-Sanchez C; Álvarez D; Zarca E; Ríos-Llorente A; Diaz-Alvarez A; Sanchez-Barrado E; Andaluz-Ojeda D; Calvo-Vecino JM; Muñoz-Bellvís L; Gomez-Herreras JI; Abad-Molina C; Bermejo-Martin JF; Aldecoa C; Heredia-Rodríguez M
    BJS Open; 2020 Jun; 4(3):524-534. PubMed ID: 32073224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study.
    Viaggi B; Poole D; Tujjar O; Marchiani S; Ognibene A; Finazzi S
    PLoS One; 2018; 13(8):e0201491. PubMed ID: 30102716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
    Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
    Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of mid-regional proadrenomedullin levels in the resuscitation phase of severely burned patients and its utility in early sepsis detection.
    Flores E; Estébanez B; Quintana M; Fernández-Puntero B; Nanwani K; Cachafeiro L; Martínez JR; Agrifoglio A; Sánchez-Sánchez M
    Burns; 2024 Aug; 50(6):1519-1527. PubMed ID: 38570251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.
    Saeed K; Wilson DC; Bloos F; Schuetz P; van der Does Y; Melander O; Hausfater P; Legramante JM; Claessens YE; Amin D; Rosenqvist M; White G; Mueller B; Limper M; Callejo CC; Brandi A; Macchi MA; Cortes N; Kutz A; Patka P; Yañez MC; Bernardini S; Beau N; Dryden M; van Gorp ECM; Minieri M; Chan L; Rood PPM; Del Castillo JG
    Crit Care; 2019 Feb; 23(1):40. PubMed ID: 30736862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of mid-regional proadrenomedullin in ARDS COVID-19 patients: the experience of a single, Italian Center.
    Benedetti I; Spinelli D; Callegari T; Bonometti R; Molinaro E; Novara E; Cassinari M; Frino C; Guaschino R; Boverio R; Lauritano EC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1743-1751. PubMed ID: 33629344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
    Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
    APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?
    Spoto S; Basili S; Cangemi R; D'Avanzo G; Lupoi DM; Romiti GF; Argemi J; Yuste JR; Lucena F; Locorriere L; Masini F; Testorio G; Calarco R; Fogolari M; Francesconi M; Battifoglia G; Costantino S; Angeletti S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of procalcitonin and mid-regional pro-adrenomedullin in septic paediatric patients.
    Solé-Ribalta A; Bobillo-Pérez S; Valls A; Girona-Alarcón M; Launes C; Cambra FJ; Jordan I; Esteban E
    Eur J Pediatr; 2020 Jul; 179(7):1089-1096. PubMed ID: 31974673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
    Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
    Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity.
    Andaluz-Ojeda D; Nguyen HB; Meunier-Beillard N; Cicuéndez R; Quenot JP; Calvo D; Dargent A; Zarca E; Andrés C; Nogales L; Eiros JM; Tamayo E; Gandía F; Bermejo-Martín JF; Charles PE
    Ann Intensive Care; 2017 Dec; 7(1):15. PubMed ID: 28185230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and predictive performance of biomarkers in patients with sepsis in an intensive care unit.
    Zhang Y; Khalid S; Jiang L
    J Int Med Res; 2019 Jan; 47(1):44-58. PubMed ID: 30477377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
    Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
    Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
    Travaglino F; De Berardinis B; Magrini L; Bongiovanni C; Candelli M; Silveri NG; Legramante J; Galante A; Salerno G; Cardelli P; Di Somma S
    BMC Infect Dis; 2012 Aug; 12():184. PubMed ID: 22874067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
    Montrucchio G; Sales G; Rumbolo F; Palmesino F; Fanelli V; Urbino R; Filippini C; Mengozzi G; Brazzi L
    PLoS One; 2021; 16(2):e0246771. PubMed ID: 33556140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.